VeriMom¿Es oligopeptide-123 rh-oligopeptide-1 seguro durante el embarazo?
No harmonised CLP reproductive classification (ECHA Annex VI) or CIR/SCCS safety opinion indicating reproductive hazard for oligopeptide‑1/rh‑oligopeptide‑1. Peer‑reviewed literature and product safety listings (CosIng, PubChem) describe it as a topical recombinant peptide (EGF) with no published developmental/teratogenic human data; dermal absorption of large peptides is generally limited, supporting negligible systemic exposure from cosmetic use (CosIng; PubMed).
Related ingredients
Frequently asked questions
- ¿Es oligopeptide-123 rh-oligopeptide-1 seguro durante el embarazo?
- No harmonised CLP reproductive classification (ECHA Annex VI) or CIR/SCCS safety opinion indicating reproductive hazard for oligopeptide‑1/rh‑oligopeptide‑1. Peer‑reviewed literature and product safety listings (CosIng, PubChem) describe it as a topical recombinant peptide (EGF) with no published developmental/teratogenic human data; dermal absorption of large peptides is generally limited, supporting negligible systemic exposure from cosmetic use (CosIng; PubMed).
- ¿Es oligopeptide-123 rh-oligopeptide-1 seguro durante la lactancia?
- No evidence of reproductive or lactation toxicity or harmonised classification. Given lack of systemic toxicity data and expected minimal dermal absorption of a peptide of this size, systemic exposure in lactating people is expected to be negligible; therefore transfer into breastmilk is unlikely based on available sources (CosIng; PubMed).
- ¿Es oligopeptide-123 rh-oligopeptide-1 seguro para la piel del bebé?
- No intrinsic reproductive hazard identified. However, infant skin has a higher surface‑area‑to‑body‑weight and a less mature barrier which increases potential exposure from topical application; therefore exposure score increased by +1 relative to adults despite overall limited dermal absorption of peptides (general dermal pharmacokinetics literature; CosIng). No infant‑specific toxicity or developmental effects documented.
- ¿Cómo puntúa VeriMom a oligopeptide-123 rh-oligopeptide-1?
- VeriMom puntúa oligopeptide-123 rh-oligopeptide-1 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a oligopeptide-123 rh-oligopeptide-1 en el embarazo?
- Consulta nuestra lista de alternativas seguras a oligopeptide-123 rh-oligopeptide-1 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.